Eczema drug afimkibart tested for Long-Term safety in new study

NCT ID NCT07223697

First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 4 times

Summary

This study looks at the long-term safety and effectiveness of the drug afimkibart for people with atopic dermatitis (eczema) who have already taken it in earlier studies. About 120 adults will be followed to see how well the drug controls their eczema over time and what side effects may occur. The goal is to understand if afimkibart remains safe and helpful for ongoing management of the condition.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Azienda Ospedaliero Universitaria delle Marche

    RECRUITING

    Ancona, The Marches, 60126, Italy

  • Best Skin Research LLC

    RECRUITING

    Camp Hill, Pennsylvania, 17011, United States

  • Centro de Estudos em Terapias Inovadoras ? CETI

    RECRUITING

    Curitiba, Paraná, 80030-110, Brazil

  • Centro de Pesquisa São Lucas

    RECRUITING

    Campinas, São Paulo, 13060-803, Brazil

  • Centrum Medyczne Pratia Gdynia

    RECRUITING

    Gdynia, 81-338, Poland

  • Centrum Medyczne Pratia Katowice I

    RECRUITING

    Katowice, Silesian Voivodeship, 40-081, Poland

  • Centrum Nowoczesnych Terapii "Dobry Lekarz"

    RECRUITING

    Krakow, 31-011, Poland

  • Clinica Universidad de Navarra

    RECRUITING

    Pamplona, Navarre, 31008, Spain

  • DermEdge

    RECRUITING

    Mississauga, Ontario, L4Y4C5, Canada

  • DermEffects

    RECRUITING

    London, Ontario, N6H 5L5, Canada

  • Dermatologikum Hamburg Gemeinschaftspraxis GbR

    RECRUITING

    Hamburg, 20354, Germany

  • Fachklinik Bad Bentheim

    RECRUITING

    Bad Bentheim, Lower Saxony, 48455, Germany

  • Fundacao Faculdade Regional de Medicina de Sao Jose Do Rio Preto Hospital de Base - PPDS

    RECRUITING

    Sao Jose Rio Preto, São Paulo, 15090-000, Brazil

  • HMCG - Hospital e Maternidade Dr. Christovo da Gama

    RECRUITING

    Santo Andr, São Paulo, 09030-010, Brazil

  • Hamilton Research, LLC

    RECRUITING

    Alpharetta, Georgia, 30022, United States

  • Hospital Universitario Reina Sofia

    RECRUITING

    Córdoba, 14004, Spain

  • Hospital de Clnicas de Porto Alegre

    RECRUITING

    Porto Alegre, Rio Grande do Sul, 90035-903, Brazil

  • Instituto Brasil de Pesquisa Clínica-IBPCLIN S/A

    RECRUITING

    Rio de Janeiro, 20241-180, Brazil

  • Irmandade Da Santa Casa de Misericordia de Porto Alegre

    RECRUITING

    Porto Alegre, Rio Grande do Sul, 90020-090, Brazil

  • Klinika Ambroziak Dermatologia

    RECRUITING

    Warsaw, 02-953, Poland

  • Lynderm Research Inc

    RECRUITING

    Markham, Ontario, L3P 1X3, Canada

  • Olympian Clinical Research

    RECRUITING

    Tampa, Florida, 33615, United States

  • Revival Research Institute, LLC

    RECRUITING

    Troy, Michigan, 48084, United States

  • Ryan Clinical Research Inc

    RECRUITING

    Newmarket, Ontario, L3Y 5G8, Canada

  • Specjalistyczny Gabinet Dermatologiczny dr n. med. Pawel Brzewski

    RECRUITING

    Krakow, 30-002, Poland

  • UCLA Division of Dermatology

    RECRUITING

    Los Angeles, California, 90024, United States

  • UNESP - Faculdade de Medicina da Universidade Estadual Paulista - Campus Botucatu

    RECRUITING

    Botucatu, São Paulo, 18618-686, Brazil

  • Uniwersytecki Szpital Kliniczny im.Fryderyka Chopina w Rzeszowie

    RECRUITING

    Rzeszów, 35-055, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.